Difficulty: Medium
Average Score: 82%
Practice
Main effect of sulfinpyrazone in hyperuricemia is
Correct answer
B
Rationale
In the context of pharmacology, specifically in the treatment of hyperuricemia, sulfinpyrazone is a medication that acts as a uricosuric agent. The main effect of sulfinpyrazone in hyperuricemia is to promote the elimination of urate from the body. This is achieved by inhibiting the reabsorption of uric acid in the kidneys, leading to an increase in the excretion of uric acid in the urine.
Option A, "Suppress the symptoms," is incorrect because sulfinpyrazone does not directly suppress the symptoms of hyperuricemia. Instead, it targets the underlying cause by increasing the elimination of uric acid.
Option C, "Prevent urate synthesis," is also incorrect because sulfinpyrazone does not interfere with the synthesis of uric acid in the body. Its mechanism of action is focused on enhancing the excretion of uric acid that has already been produced.
Option D, "All of the above," is incorrect because while sulfinpyrazone does promote the elimination of urate, it does not suppress symptoms or prevent urate synthesis.
In an educational context, understanding the specific mechanisms of action of medications like sulfinpyrazone is crucial for healthcare professionals to make informed decisions regarding the management of hyperuricemia. By grasping how sulfinpyrazone promotes urate elimination, healthcare providers can effectively prescribe and monitor its use in patients with this condition, ultimately improving patient outcomes.
Option A, "Suppress the symptoms," is incorrect because sulfinpyrazone does not directly suppress the symptoms of hyperuricemia. Instead, it targets the underlying cause by increasing the elimination of uric acid.
Option C, "Prevent urate synthesis," is also incorrect because sulfinpyrazone does not interfere with the synthesis of uric acid in the body. Its mechanism of action is focused on enhancing the excretion of uric acid that has already been produced.
Option D, "All of the above," is incorrect because while sulfinpyrazone does promote the elimination of urate, it does not suppress symptoms or prevent urate synthesis.
In an educational context, understanding the specific mechanisms of action of medications like sulfinpyrazone is crucial for healthcare professionals to make informed decisions regarding the management of hyperuricemia. By grasping how sulfinpyrazone promotes urate elimination, healthcare providers can effectively prescribe and monitor its use in patients with this condition, ultimately improving patient outcomes.